BioSpace4h
7 Indications for GLP-1s Beyond Weight Loss
Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...
ConsumerAffairs7h
FDA approves Zepbound as a treatment for obstructive sleep apnea
Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and ...
Tired of CPAP? FDA approval of Zepbound introduces new treatment for sleep apnea
"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in ...
FDA approves weight-loss drug Zepbound to treat sleep apnea
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...
FDA Approves Lilly's Zepbound To Treat Obstructive Sleep Apnea In Adults With Obesity
The U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea ...
Eli Lilly Gets FDA Approval for Zepbound for Certain Sleep Apnea Patients
Eli Lilly said the FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, the first and ...
MedPage Today2d
FDA Approves First Sleep Apnea Drug
"Today's approval marks the first drug treatment option for certain patients with obstructive sleep apnea," said Sally ...
The First Sleep Apnea Drug Is Here
T he weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by ...